Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Menéndez, Rosario et al., 2017
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/122995

Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background: Non-cystic fibrosis bronchiectasis is a chronic structural lung condition that courses with recurrent infectious exacerbations that lead to frequent antibiotic treatment making this population more susceptible to acquire pathogens with antibiotic resistance. We aimed to investigate risk factors associated with isolation of multidrug-resistant pathogens in bronchiectasis exacerbations. Methods: A prospective observational study was conducted in two tertiary-care hospitals, enrolling patients when first exacerbation appeared. Multidrug-resistance was determined according to European Centre of Diseases Prevention and Control classification. Results: Two hundred thirty three exacerbations were included and microorganisms were isolated in 159 episodes. Multidrug-resistant pathogens were found in 20.1% episodes: Pseudomonas aeruginosa (48.5%), methicillin-resistant Staphylococcus aureus (18.2%) and Extended spectrum betalactamase + Enterobacteriaceae (6.1%), and they were more frequent in exacerbations requiring hospitalization (24.5% vs. 10.2%, p: 0.016). Three independent multidrugresistant risk factors were found: chronic renal disease (Odds ratio (OR), 7.60, 95% CI 1.92-30.09), hospitalization in the previous year (OR, 3.88 95% CI 1.37-11.02) and prior multidrug-resistant isolation (OR, 5.58, 95% CI 2.02-15.46). The proportion of multidrug-resistant in the 233 exacerbations was as follows: 3.9% in patients without risk factors, 12.6% in those with 1 factor and 53.6% if ≥2 risk factors. Conclusions: Hospitalization in the previous year, chronic renal disease, and prior multidrug-resistant isolation are risk factors for identification multidrug-resistant pathogens in exacerbations. This information may assist clinicians in choosing empirical antibiotics in daily clinical practice.

Citació

Citació

MENÉNDEZ, Rosario, MÉNDEZ, Raúl, POLVERINO, Eva, ROSALES MAYOR, Edmundo, AMARA ELORI, Isabel, REYES, Soledad, SAHUQUILLO ARCE, José miguel, FERNÁNDEZ BARAT, Laia, ALCARAZ, Victoria, TORRES MARTÍ, Antoni. Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations. _Bmc Infectious Diseases_. 2017. Vol. 17, núm. 659. [consulta: 24 de gener de 2026]. ISSN: 1471-2334. [Disponible a: https://hdl.handle.net/2445/122995]

Exportar metadades

JSON - METS

Compartir registre